Description
For more than six decades, Interlabor Belp AG has established itself as a trusted and independent provider of GMP-compliant analytical services to the pharmaceutical industry. Their expertise encompasses both routine and highly specialized analyses, including raw material testing, finished product release, stability studies, and the characterization or identification of unknown substances and particles. The laboratory also offers comprehensive method development and validation services to support a wide range of analytical needs. In recent years, Interlabor has built strong expertise in the detection and quantification of nitrosamines, helping clients comply with evolving regulatory expectations in this critical area.
Clients particularly value Interlabor’s strong troubleshooting capabilities, flexibility in adapting to diverse project needs, and their reputation for reliability and punctual delivery.
By tailoring analytical concepts to complex challenges, Interlabor consistently combines scientific rigor with strict adherence to regulatory requirements, making them a long-standing and dependable partner for pharmaceutical companies and CDMOs alike.
Company (Headquarters):
Switzerland
Company Products and Services:
Active Pharmaceutical Ingredients;Animal Healthcare;Biologics;Clinical Research;CMO/CDMO;Consultancy;Excipients;Finished Dosage Formulation;Generic APIs;Intermediates;Packaging and Drug Delivery;Quality Control and Certification;Cold Storage
Number of Facilities:
1
Facilities Location:
Europe
Capabilities
Contact Information
Related Listings

AI + Digital Maturity in Contract Manufacturing 2026
Exclusive research roundtable on Day Zero of CDMO Live Americas 2026, in partnership with MasterControl

External Manufacturing Leaders Basel 2026
Exclusive event for senior external manufacturing leaders. Basel











